Novo Nordisk raced to meet demand for its weight-loss drug Wegovy and almost doubled its workforce over five years. Now, the ...

With the price of Mounjaro set to almost triple in the UK, there are fears more and more people will turn to counterfeits.

What goes up must come down — here are the major drugs falling the hardest at the top companies so far this year.

Novo Nordisk faces potential layoffs after a period of rapid expansion fueled by the success of Wegovy. The company's ...

In teaming up with Williams, Ro's goal is to destigmatize the use of GLP-1 treatments for weight loss. This follows Ro's recruitment of NBA Hall of Famer and five-time Sports Emmy ...

Most investors have noticed that most stocks in the healthcare sector have declined to levels not seen in a while, making ...

With the cost of the weight-loss jab set to rise by up to 170 per cent, Jade Kay, who has already spent £2,400 on the drug, says she will take a second job waitressing if she has to ...

With promising new obesity treatments in the pipeline, 24/7 Wall St. projects huge upside for Novo Nordisk stock through 2030.

When bad news drops, investors have a tendency to sell first and ask questions later. Let's take a closer look at why Viking ...